Showing results (111-120 of 170) with videos related to
Sort By:
Pageof 17
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 1, 2005
Aldosterone blunts human baroreflex sensitivity by a nongenomic mechanismB M W Schmidt, K Horisberger, M Feuring, et al.Acta Endocrinologica|December 1, 1987
Effects of aldosterone on intralymphocytic sodium and potassium in patients with primary aldosteronismM Wehling, S Kuhls, H Witzgall, et al.FEBS Letters|June 1, 2000
Dominant negative myostatin produces hypertrophy without hyperplasia in muscleX Zhu, M Hadhazy, M Wehling, et al.Circulation Research|June 1, 1995
Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cellsM Wehling, C B Neylon, M Fullerton, et al.Clinical Science (London, England : 1979)|May 1, 1984
Angiotensin II binding to human mononuclear cells: receptor or free fluid endocytosis?L Neyses, R Locher, M Wehling, et al.MMW Fortschritte Der Medizin|September 28, 2000
[Guidelines for lowering lipids are too infrequently observed. Results of a retrospective study of coronary heart disease patients]G Klein, J Ruof, W März, et al.Preventive Medicine|June 25, 2002
Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patternsJ Ruof, G Klein, W März, et al.Hypertension (Dallas, Tex. : 1979)|January 1, 1995
Rapid effects of aldosterone on sodium transport in vascular smooth muscle cellsM Christ, K Douwes, C Eisen, et al.Drug Research|October 7, 2014
Optimal Stroke Prevention in the Geriatric Patient with Atrial Fibrillation: Position Paper of an Interdisciplinary Expert PanelP Bahrmann, M Wehling, D Ropers, et al.MMW Fortschritte Der Medizin|November 25, 2014
[Optimal stroke prevention in the geriatric patient with atrial fibrillation: position paper of an interdisciplinary expert panel]P Bahrmann, M Wehling, D Ropers, et al.Pageof 17